联系客服

600436 沪市 片仔癀


首页 公告 片仔癀:漳州片仔癀药业股份有限公司2023年前三季度主要经营数据公告

片仔癀:漳州片仔癀药业股份有限公司2023年前三季度主要经营数据公告

公告日期:2023-10-17

片仔癀:漳州片仔癀药业股份有限公司2023年前三季度主要经营数据公告 PDF查看PDF原文

 证券代码:600436    证券简称:片仔癀    公告编号:2023-027
          漳州片仔癀药业股份有限公司

        2023 年前三季度主要经营数据公告

  本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。

  根据《上海证券交易所上市公司自律监管指引第三号——行业信息披露(2022 年修订)》《上市公司行业信息披露指引第六号——医药制造(2022 年修订)》等相关法律法规,漳州片仔癀药业股份有限公司(以下简称“公司”)现将 2023 年前三季度主要经营数据披露如下:

  一、 公司 2023 年前三季度主营业务分行业情况

                                            单位:万元人民币

                                            主营业  主营业

            主营业务    主营业务  毛利率  务收入  务成本  毛利率
  行业

              收入        成本    (%)  增长率  增长率  增减情况
                                            (%)  (%)

  医药                                                    减少 3.11
            385,235.46  95,398.23  75.24  22.51  40.14

  制造业                                                    个百分点

  医药                                                    增加 2.52
            305,889.50  257,476.90  15.83  6.88    3.77

  流通业                                                    个百分点

 医药行业                                                  增加 1.58
            691,124.96  352,875.13  48.94  15.06  11.60

  小计                                                      个百分点

                                                            增加 1.47
 化妆品业  43,078.41  15,875.46  63.15  -6.53  -10.10

                                                            个百分点

                                                            增加 0.56
  其他    24,293.50  21,718.95  10.60  84.31  83.16

                                                            个百分点

                                                            增加 0.91
  合计    758,496.87  390,469.54  48.52  14.94  12.94

                                                            个百分点


  二、 公司 2023 年前三季度主营业务分类别情况

                                            单位:万元人民币

                                          主营业  主营业

            主营业务    主营业务  毛利率  务收入  务成本  毛利率
 分类别

              收入        成本    (%)  增长率  增长率  增减情况
                                            (%)  (%)

  肝病                                                    减少 2.15
  用药    356,217.15  77,702.47  78.19  19.84  32.95

                                                            个百分点

 心脑血管                                                  减少 7.52
  用药    24,042.72  14,424.61  40.00  79.34  105.02

                                                            个百分点

  其他                                                      增加 2.6
            4,975.59    3,269.94  34.28  30.95  25.96

                                                            个百分点

 医药制造                                                  减少 3.11
 业小计  385,235.46  95,397.02  75.24  22.51  40.13

                                                            个百分点

 医药流通                                                  增加 2.52
 业小计  305,889.50  257,476.90  15.83  6.88    3.77

                                                            个百分点

 医药行业                                                  增加 1.58
  小计    691,124.96  352,873.92  48.94  15.06  11.60

                                                            个百分点

化妆品业                                                    增加 1.47
          43,078.41  15,875.46  63.15  -6.53  -10.10

                                                            个百分点

  其他                                                    增加 0.56
          24,293.50  21,718.95  10.60  84.31  83.16

                                                            个百分点

  合计                                                    增加 0.91
          758,496.87  390,468.33  48.52  14.94  12.94

                                                            个百分点


  三、 公司 2023 年前三季度主营业务分地区情况

                                            单位:万元人民币

        地区              主营业务收入        同比上年增减(%)

      东北地区                    11,513.28                  39.35

      华北地区                    41,398.60                  12.81

      华东地区                  522,155.21                  12.08

      华南地区                    81,501.92                  21.79

      华中地区                    42,512.16                  48.95

      西北地区                    7,792.77                  27.37

      西南地区                    23,072.98                  42.43

      境外地区                    28,549.95                  -8.83

        合计                    758,496.87                  14.94

  说明:(1)上表中地区分布以客户公司所在地划分。

        (2)境内各地区收入变化主要系医药行业销售变化所致。
  四、其它对公司生产经营产生重大影响的事件

  无。

  上述的主要经营数据信息来源于公司报告期内财务数据,且未经审计,仅供投资者及时了解公司生产经营情况。敬请广大投资者审慎使用,理性投资,注意风险。

  特此公告。

                                  漳州片仔癀药业股份有限公司
                                        董  事  会

                                        2023 年 10 月 17 日

[点击查看PDF原文]